Treatment de-escalation in Crohn's disease

Lancet Gastroenterol Hepatol. 2023 May;8(5):401. doi: 10.1016/S2468-1253(23)00073-0.

Authors

Cathy McShane¹, David Kevans²

Affiliations

¹ Department of Gastroenterology, St James's Hospital, Dublin D08 NHY1, Ireland; School of Medicine, Trinity College Dublin, Dublin, Ireland. Electronic address: [email protected].
² Department of Gastroenterology, St James's Hospital, Dublin D08 NHY1, Ireland; School of Medicine, Trinity College Dublin, Dublin, Ireland.

PMID: 37030299
DOI: 10.1016/S2468-1253(23)00073-0

No abstract available

Publication types

Letter
Comment

MeSH terms

Adalimumab
Crohn Disease* / drug therapy
Humans
Infliximab

Substances

Adalimumab
Infliximab